Gender issues in cardiovascular diseases. Focus on energy metabolism.


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 09 10 2019
revised: 20 01 2020
accepted: 07 02 2020
pubmed: 15 2 2020
medline: 21 10 2020
entrez: 15 2 2020
Statut: ppublish

Résumé

It is increasingly recognized that sex and gender differences (S&G) influence cardiovascular diseases (CVD), greatly impacting disease management. In terms of definition, sex refers to biological aspects, gender effects being mainly related to socio-cultural factors. Both sex and gender are interpenetrated in humans and difficult to separate. This is more clearly feasible in animal models where sex effects largely predominate. As alterations in energy metabolism are essential features of cardiovascular diseases, sexual dimorphism of energy metabolism and more specifically mitochondria occupies a place of choice. This review presents the basis of sex and gender differences in the cardiovascular pathophysiology, and how it mainly affects woman diseases, effectiveness of therapies and clinical outcome. These differences rely on complex molecular mechanisms that are still poorly understood because of the under-representation of females/women in experimental and clinical studies. Finally, the differing psychological and biological phases of woman's life are largely underestimated. This review presents an overview of the field with focus on differences in cardiac energy metabolism, which are illustrated with specific examples.

Identifiants

pubmed: 32057941
pii: S0925-4439(20)30067-3
doi: 10.1016/j.bbadis.2020.165722
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

165722

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

R Ventura-Clapier (R)

Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Châtenay-Malabry, France. Electronic address: renee.ventura@u-psud.fr.

J Piquereau (J)

Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Châtenay-Malabry, France.

A Garnier (A)

Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Châtenay-Malabry, France.

M Mericskay (M)

Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Châtenay-Malabry, France.

C Lemaire (C)

Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Châtenay-Malabry, France; Université Versailles St-Quentin, France.

B Crozatier (B)

Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Châtenay-Malabry, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH